January 11, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endeavour Mining PLC (“Endeavour” or “the Company”) (OTC: EDVMF; TSX: EDV). Investors who purchased Endeavour securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Endeavour has… read more
January 10, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spirit Aerosystems Holdings, Inc. (“Spirit” or “the Company”) (NYSE: SPR). Investors who currently hold Spirit securities are encouraged to obtain additional information and assist the investigation. Investigation Details: The investigation concerns… read more
January 4, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Carlyle Credit Income Fund f/k/a Vertical Capital Income Fund (“the Fund” or “the Company”) (NYSE: CCIF; VCIF). Investors who purchased the Fund securities are encouraged to obtain additional information and assist… read more
January 3, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MiMedx Group, Inc. (“MiMedx” or “the Company”) (NASDAQ: MDXG). Investors who purchased MiMedx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MiMedx has violated… read more
January 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grand Canyon Education, Inc. (“GCE” or “the Company”) (NASDAQ: LOPE). Investors who purchased GCE securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GCE has… read more
January 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of First Trust DorseyWright DALI 1 ETF (“test23” or “the Company”) (NASDAQ: DALI). Investors who purchased test23 securities prior to December 28, 2023, and continue to hold to the present, are encouraged… read more
January 1, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Del Taco Restaurants, Inc. (“test20” or “the Company”) (NASDAQ: TACO). Investors who purchased test20 securities prior to December 26, 2023, and continue to hold to the present, are encouraged to obtain… read more
December 28, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytosorbents Corporation (“Cytosorbents” or “the Company”) (NASDAQ: CTSO). Investors who purchased Cytosorbents securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cytosorbents has violated federal… read more
December 20, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FIGS, Inc. (“FIGS” or “the Company”) (NYSE: FIGS). Investors who purchased FIGS securities prior to May 27, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
December 20, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SCYNEXIS, Inc. (“Scynexis” or “the Company”) (NASDAQ: SCYX). Investors who purchased Scynexis securities prior to March 31, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more
December 20, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Holley Inc. (“Holley” or “the Company”) (NYSE: HLLY). Investors who purchased Holley securities prior to July 21, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
December 18, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alteryx, Inc. (“Alteryx” or “the Company”) (NYSE: AYX). Investors who purchased Alteryx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alteryx has violated federal… read more
December 12, 2023 |
Gildan Activewear Inc. (GIL) Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gildan Activewear Inc. (“Gildan” or “the Company”) (NYSE: GIL). Investors who purchased Gildan securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
December 11, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Procter & Gamble Company (“Procter & Gamble” or “the Company”) (NYSE: PG). Investors who purchased Procter & Gamble securities are encouraged to obtain additional information and assist the investigation. The… read more
December 11, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blackstone Mortgage Trust, Inc. (“Blackstone” or “the Company”) (NYSE: BXMT). Investors who purchased Blackstone securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Blackstone has… read more
November 29, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rover Group, Inc. (“Rover” or “the Company”) (NASDAQ: ROVR). Investors who purchased Rover securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether the sale of… read more
November 28, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tailwind Acquisition Corp. (“Tailwind”), which merged with NUBURU, Inc. (“NUBURU”) (NYSE: BURU) on February 1, 2023. Investors who purchased Tailwind and continue to hold to the present, are encouraged to obtain… read more
November 14, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN). Investors who purchased Illumina securities prior to September 21, 2020, and continue to hold to the present, are encouraged to obtain additional information… read more
July 14, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Forest Road Acquisition Corp. (“Forest Road”), which merged with The Beachbody Company Group, LLC (“Beachbody”) (NYSE: BODY) on June 28, 2021. Such investors who purchased Forest Road and continue to hold Beachbody to the present are encouraged to obtain additional information and assist the investigation…. read more
October 2, 2024 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Brainstorm Cell Therapeutics Inc. (“TEST_SN”) (NYSE: BCLI) and None (“None”) (None: None). Investors who purchased TEST_SN and continue to hold to the present are encouraged to obtain additional information and assist the investigation by visiting… read more
June 13, 2023 |
Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Expensify, Inc. (“Expensify” or “the Company”) (NASDAQ: EXFY) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more
April 27, 2023 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC). Investors who purchased Sotera securities prior to January 2022, and continue to hold to the present, are encouraged to obtain additional information… read more